These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 19177462)

  • 1. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
    Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
    Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome analysis of serum from type 2 diabetics with nephropathy.
    Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
    J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
    Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
    Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
    Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
    J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
    Riaz S; Skinner V; Srai SK
    J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
    Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
    Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
    Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change and significance of urinary smad3 in type 2 diabetic nephropathy].
    Guo KF; Kou JX; Lu JX; Zhang L; Yu HY; Chen HB
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1067-71. PubMed ID: 23902838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does bacteriuria interfere with albuminuria measurements of patients with diabetes?
    Kramer CK; Camargo J; Ricardo ED; Almeida FK; Canani LH; Gross JL; Azevedo MJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1193-6. PubMed ID: 19015170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer.
    Protheroe AS; Banks RE; Mzimba M; Porter WH; Southgate J; Singh PN; Bosomworth M; Harnden P; Smith PH; Whelan P; Selby PJ
    Br J Cancer; 1999 Apr; 80(1-2):273-8. PubMed ID: 10390008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
    Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
    J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P; Chan SP
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary pigment epithelium-derived factor as a marker of diabetic nephropathy.
    Chen H; Zheng Z; Li R; Lu J; Bao Y; Ying X; Zeng R; Jia W
    Am J Nephrol; 2010; 32(1):47-56. PubMed ID: 20523035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR; Kim IS; Kang YS; Han SY; Han KH; Shin C; Ji YH; Kim NH
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.